Antares Pharma (ATRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2006 | 12-2005 | 12-2004 | 12-2003 | 12-2002 | |
| Sales | 4,268 | 2,225 | 2,746 | 3,787 | 3,996 |
| Cost of Goods | 1,556 | 1,137 | 1,372 | 2,008 | 2,573 |
| Gross Profit | 2,712 | 1,088 | 1,374 | 1,779 | 1,423 |
| Operating Expenses | 11,545 | 9,814 | 10,121 | 10,421 | 12,258 |
| Operating Income | -8,277 | -8,589 | -8,375 | -8,634 | -10,262 |
| Interest Expense | 3 | 1 | 101 | 920 | 1,297 |
| Other Income | 180 | 92 | 127 | -23,264 | -50 |
| Pre-tax Income | -8,100 | -8,498 | -8,349 | -32,818 | -11,609 |
| Net Income Continuous | -8,100 | -8,498 | -8,349 | -32,818 | -11,609 |
| Net Income | $-8,100 | $-8,498 | $-8,349 | $-32,818 | $-11,609 |
| EPS Basic Total Ops | -0.16 | -0.21 | -0.23 | -2.18 | -1.22 |
| EPS Basic Continuous Ops | -0.16 | -0.21 | -0.23 | -2.17 | -1.21 |
| EPS Diluted Total Ops | -0.16 | -0.21 | -0.23 | -2.18 | -1.22 |
| EPS Diluted Continuous Ops | -0.16 | -0.21 | -0.23 | -2.17 | -1.21 |
| EBITDA(a) | $-7,783 | $-8,076 | $-7,598 | $-7,740 | $-7,355 |